Agreed that COvid has delayed most of the clinical trials, and...

Agreed that COvid has delayed most of the clinical trials, and lost some focus on Covid opportunities too. As far as I can tell we now appear to be getting back to basics and focussing once again on our main assets, that of stopping diarrhea and fatty liver disease - both of which are major breakthroughs and should boost income enormously. We have plenty of cash, so the only real question is when this will happen and that is much harder to answer. This share is my long term bucket with a target selling price of $1 so it might be a while!!